The future beyond tomorrow: lessons learned from the COVID-19 pandemic

This webinar is the third in a series that will address issues that healthcare providers may face when they treat patients with immune-mediated inflammatory diseases (IMIDs) during the COVID-19 pandemic. This one-hour session will start off with a keynote presentation on the virology of COVID-19 and what we have learned to date. It will be followed by a panel discussion on possible strategies that can be applied to manage patients with IMIDs in the future. The viewers worldwide will then have the opportunity to engage with the faculty during the interactive segment of the webinar.

We hope you can join us during this live, interactive session. If you are unable to attend the live broadcast, you will have the opportunity to watch the on-demand version once it is available.

Learning objectives

After this webinar, participants should be able to:

• Evaluate best practices in managing patients with immune-mediated inflammatory diseases (IMIDs) during the current COVID-19 pandemic
• Understand, from virology and epidemiology viewpoints, how to make plans for future patient management
• Discuss how the evolution of the pandemic will shape the treatment of IMIDs

Faculty

• Kilian Eyerich (Germany) (Scientific Committee)
• Paul Klenerman (UK)
• Iain McInnes (UK) (Scientific Committee)
• Laurent Peyrin-Biroulet (France) (Scientific Committee)
• Emma Thomson (UK)

Programme (All times are shown in CEST)

20:00–20:05 Welcome and introduction
Iain McInnes

20:05–20:20 The endgame: what have we learned from SARS-CoV-2
Paul Klenerman (UK) and Emma Thomson (UK)

20:20–20:45 A “new normal” for IMID management: our view of future healthcare – panel discussion
Kilian Eyerich, Iain McInnes, & Laurent Peyrin-Biroulet

20:45–21:00 Live Q&A session with the audience
All faculty